Balyasny Asset Management L.P.
Position in ARWR — Arrowhead Pharmaceuticals, Inc.
CIK 1218710
Chicago, IL
Position in ARWR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$38,371,158
+$25,429,126 QoQ
Shares Held
470,754
+128.1% QoQ
Ownership
0.333%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#45
of 497 holders
Holding Since
Sep 2020
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARWR Over Time
Shares Held
Position Value (USD)
Derivatives in ARWR
reported options exposure · as of Sep 30, 2022CallValue
$1,652,500
CallShares
50,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Balyasny Asset Management L.P. holds $2,350,910,046 across 177 Biotechnology names. ARWR ranks #14 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | APGE |
Apogee Therapeutics, Inc.
|
1,665,102 | $221,008,988 | |
| 2 | INSM |
INSMED Inc
|
1,326,430 | $141,423,966 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
1,230,052 | $91,614,272 | |
| 4 | ABVX |
Abivax S.A.
|
603,840 | $80,467,718 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
145,005 | $72,028,333 | |
| 6 | TNGX |
Tango Therapeutics, Inc.
|
2,016,379 | $63,032,007 | |
| 7 | CYTK |
Cytokinetics Inc
|
711,676 | $60,627,678 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
1,054,613 | $60,344,955 |
All Filings in ARWR
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $38,371,158 | 470,754 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $12,942,032 | 206,412 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $24,976,980 | 376,216 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $27,349,397 | 792,966 | Shares | Sole | 2025-11-14 | |
| 2025-03-31 | $1,270,471 | 99,723 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $7,007,681 | 372,749 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,972,873 | 101,852 | Shares | Sole | 2024-11-14 | |
| 2023-03-31 | $7,005,014 | 275,788 | Shares | Other | 2023-05-15 | |
| 2022-12-31 | $218,211 | 5,380 | Shares | Other | 2023-02-14 | |
| 2022-09-30 | $5,806,322 | 175,683 | Shares | Other | 2022-11-15 | |
| 2022-09-30 | $1,652,500 | 50,000 | Call | Sole | 2022-11-15 | |
| 2022-06-30 | $6,203,790 | 176,194 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $928,124 | 20,181 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $680,039 | 10,257 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $6,010,136 | 96,270 | Shares | Sole | 2021-12-01 | |
| 2021-09-30 | $1,885,386 | 30,200 | Call | Sole | 2021-12-01 | |
| 2021-06-30 | $10,766,600 | 130,000 | Call | Sole | 2021-08-16 | |
| 2020-12-31 | $2,650,484 | 34,543 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,291,800 | 30,000 | Call | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||